Clinical Trials Directory

Trials / Completed

CompletedNCT03510156

Treatment of Disruptive Behaviors in Fragile X Syndrome

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Stanford University · Academic / Other
Sex
Male
Age
3 Years – 10 Years
Healthy volunteers
Not accepted

Summary

Disruptive behaviors such as self-injury, aggression, and property destruction pose significant health-related issues to children diagnosed with fragile X syndrome (FXS), impacting the child's quality of life and causing significant distress to families. Access to appropriate treatment for families is severely limited by factors such as cost of care, shortages of qualified treatment providers, and geographic spread of children with FXS across the country. To address these potential issues, the effectiveness of administering a standardized function-based behavioral treatment for problem behaviors in FXS will be evaluated using telemedicine. The proposed study intervention therefore offers a tremendous step forward in clinical research both in the field of FXS and in the field of developmental disabilities more broadly, and thus will have a significant impact on public health.

Conditions

Interventions

TypeNameDescription
BEHAVIORALBehavior analytic treatmentFunction-based treatment

Timeline

Start date
2016-07-01
Primary completion
2022-03-01
Completion
2022-03-01
First posted
2018-04-27
Last updated
2022-05-04

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03510156. Inclusion in this directory is not an endorsement.